
Zealand Pharma Investor Relations Material
Latest events

Q2 2025
Zealand Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Zealand Pharma
Access all reports
Zealand Pharma, a biotechnology company, engages in discovery, development, and commercialization of peptide therapeutics for metabolic diseases, gastrointestinal diseases and diseases of the central nervous system in Denmark.
Key slides for Zealand Pharma


Q2 2025
Zealand Pharma


Q2 2025
Zealand Pharma
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ZEAL
Country
🇩🇰 Denmark